
Sign up to save your podcasts
Or


🎙️ Podcast Description
Have you ever hesitated to bring a new product into your practice because it felt like “one more thing” for an already busy team? In this episode of Podiatry Practice Mastery, Don walks through his real-world decision process for introducing a new product—what worked, what caused friction, and what he’d change next time.
Using his early experience with EBM Medical as a case study, Don breaks down how to evaluate vendors, reduce staff overwhelm, protect patient trust, and decide whether a lower-dollar add-on is actually worth the squeeze compared to higher-value treatments like shockwave and orthotics.
This is a practical, unfiltered look at product integration from a busy, multi-doctor practice—not a sales pitch.
⸻
📌 Key Topics Covered (Accurate Timestamps @ 169 WPM)
[0:00] Why adding new products feels risky in a busy practice
The challenge of decision-making in a multi-doctor, multi-office environment.
[1:35] Why EBM Medical stood out as a vendor
What Don looks for in companies that approach practices the right way.
[3:00] Involving all partners before making product decisions
Why unilateral decisions fail in group practices—and what works better.
[4:30] Drop-shipping vs in-office dispensing
Why patients don’t follow through when you send them “somewhere else.”
[6:10] Early wins: how Don is using EBM products clinically
Anti-inflammatory options, fibromas, Raynaud’s, neuropathy, and realistic expectations.
[8:20] The 3-month trial mindset (and why follow-ups matter)
Using products to create accountability and meaningful reassessment visits.
[9:45] Trying products without committing to inventory
Testing Tin products before deciding whether to stock them in-office.
[11:00] Friction points: logins, training, and workflow disruption
What slowed adoption—and how vendors could improve onboarding.
[12:40] Favorites lists and standardizing usage across doctors
How shared favorites reduce confusion and speed adoption.
[14:05] What vendors should teach (but usually don’t)
Why short “how-to” videos and real doctor protocols matter.
[15:45] Notification overload and managing rep communication
Where enthusiasm turns into friction.
[17:00] Prescribing vs selling: patient psychology matters
Why “I’m prescribing this” feels very different than “buy this on the way out.”
[18:45] Marketing integration: protocols, follow-ups, and perception
Where these products fit—and where they don’t.
[20:10] The real question: is the juice worth the squeeze?
Comparing $60 products to $600–$1,500 treatments and deciding where to focus.
[22:10] Website links vs direct prescribing
Why Don prefers prescription-based credibility.
[23:30] Final thoughts + invitation for peer feedback
Asking other podiatrists what’s working (and what isn’t).
⸻
🎯 Core Takeaway
New products should reduce friction, not add it. If they don’t fit cleanly into your protocols, explanations, and follow-up structure, even “good” products can become distractions.
By Don Pelto, DPM5
1414 ratings
🎙️ Podcast Description
Have you ever hesitated to bring a new product into your practice because it felt like “one more thing” for an already busy team? In this episode of Podiatry Practice Mastery, Don walks through his real-world decision process for introducing a new product—what worked, what caused friction, and what he’d change next time.
Using his early experience with EBM Medical as a case study, Don breaks down how to evaluate vendors, reduce staff overwhelm, protect patient trust, and decide whether a lower-dollar add-on is actually worth the squeeze compared to higher-value treatments like shockwave and orthotics.
This is a practical, unfiltered look at product integration from a busy, multi-doctor practice—not a sales pitch.
⸻
📌 Key Topics Covered (Accurate Timestamps @ 169 WPM)
[0:00] Why adding new products feels risky in a busy practice
The challenge of decision-making in a multi-doctor, multi-office environment.
[1:35] Why EBM Medical stood out as a vendor
What Don looks for in companies that approach practices the right way.
[3:00] Involving all partners before making product decisions
Why unilateral decisions fail in group practices—and what works better.
[4:30] Drop-shipping vs in-office dispensing
Why patients don’t follow through when you send them “somewhere else.”
[6:10] Early wins: how Don is using EBM products clinically
Anti-inflammatory options, fibromas, Raynaud’s, neuropathy, and realistic expectations.
[8:20] The 3-month trial mindset (and why follow-ups matter)
Using products to create accountability and meaningful reassessment visits.
[9:45] Trying products without committing to inventory
Testing Tin products before deciding whether to stock them in-office.
[11:00] Friction points: logins, training, and workflow disruption
What slowed adoption—and how vendors could improve onboarding.
[12:40] Favorites lists and standardizing usage across doctors
How shared favorites reduce confusion and speed adoption.
[14:05] What vendors should teach (but usually don’t)
Why short “how-to” videos and real doctor protocols matter.
[15:45] Notification overload and managing rep communication
Where enthusiasm turns into friction.
[17:00] Prescribing vs selling: patient psychology matters
Why “I’m prescribing this” feels very different than “buy this on the way out.”
[18:45] Marketing integration: protocols, follow-ups, and perception
Where these products fit—and where they don’t.
[20:10] The real question: is the juice worth the squeeze?
Comparing $60 products to $600–$1,500 treatments and deciding where to focus.
[22:10] Website links vs direct prescribing
Why Don prefers prescription-based credibility.
[23:30] Final thoughts + invitation for peer feedback
Asking other podiatrists what’s working (and what isn’t).
⸻
🎯 Core Takeaway
New products should reduce friction, not add it. If they don’t fit cleanly into your protocols, explanations, and follow-up structure, even “good” products can become distractions.